Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
2 (100.0%)Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase 1
Recruiting
- Conditions
- Cardiovascular DisordersNeurologic DisordersIntegumentary DiseaseAutoimmune DiseasesMusculoskeletal DisordersSexual DysfunctionNeurodegenerative DisordersPulmonary DisordersUrologic DisordersDiabetes Complications
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Thomas Advanced Medical LLC
- Target Recruit Count
- 5000
- Registration Number
- NCT04684602
- Locations
- πΊπΈ
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States
Mesenchymal Stem Cells for the Treatment of COVID-19
Phase 1
Completed
- Conditions
- ProphylaxisCovid19
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Thomas Advanced Medical LLC
- Target Recruit Count
- 40
- Registration Number
- NCT04573270
- Locations
- πΊπΈ
Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California, United States
News
No news found